Teamwork Financial Advisors LLC Has $1.41 Million Stock Position in UnitedHealth Group Incorporated $UNH

Teamwork Financial Advisors LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 689.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,509 shares of the healthcare conglomerate’s stock after acquiring an additional 3,938 shares during the quarter. Teamwork Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,407,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the stock. GAMMA Investing LLC grew its holdings in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after buying an additional 8,280,404 shares in the last quarter. Nuveen LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth $3,846,764,000. Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of recent analyst reports. Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Wolfe Research lowered their target price on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 20th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. TD Securities reissued a “hold” rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Wells Fargo & Company dropped their price objective on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $358.95.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $352.61 on Friday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock has a market capitalization of $319.35 billion, a P/E ratio of 15.28, a PEG ratio of 2.31 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm’s 50 day moving average is $291.98 and its 200 day moving average is $369.01.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.